November 18, 2024 Access EU24 Barcelona We are delighted to share highlights from our recent participation in the ACCESS EU 2024 conference, held in Barcelona from November 14-16. The event brought together industry leaders, policy experts, and healthcare i…
November 6, 2024 How GenAI techniques can transform policy landscape analysis and monitoring As an AI enthusiast, I recently had the privilege of advising on an ambitious project – Market4Health, a platform designed to explore the boundaries of…
March 12, 2024 Vaccines: Today and Beyond In the 21st century, we have witnessed a staggering number of major infectious disease outbreaks: SARS in 2003, H1N1 swine flu in 2009, MERS in 2012, Ebola i…
October 28, 2023 Novel treatments for neurodegenerative diseases Currently, around 50 million people worldwide are suffering from various neurodegenerative diseases, out of them about 7 million are in the USA. Brain diseas…
November 18, 2024 Access EU24 Barcelona We are delighted to share highlights from our recent participation in the ACCESS EU 2024 conference, held in Barcelona from November 14-16. The event brought…
November 6, 2024 How GenAI techniques can transform policy landscape analysis and monitoring As an AI enthusiast, I recently had the privilege of advising on an ambitious project – Market4Health, a platform designed to explore the boundaries of…
March 12, 2024 Vaccines: Today and Beyond In the 21st century, we have witnessed a staggering number of major infectious disease outbreaks: SARS in 2003, H1N1 swine flu in 2009, MERS in 2012, Ebola i…
October 28, 2023 Novel treatments for neurodegenerative diseases Currently, around 50 million people worldwide are suffering from various neurodegenerative diseases, out of them about 7 million are in the USA. Brain diseas…
